These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7601899)

  • 1. Unraveling the causes of hypertension and hypokalemia.
    Steigerwalt SP
    Hosp Pract (1995); 1995 Jul; 30(7):67-71, 74-5, 79. PubMed ID: 7601899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension and hypokalemia: unusual syndromes.
    Cruz DN; Perazella MA
    Conn Med; 1997 Feb; 61(2):67-75. PubMed ID: 9066195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoid-remediable aldosteronism.
    McMahon GT; Dluhy RG
    Cardiol Rev; 2004; 12(1):44-8. PubMed ID: 14667264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Endocrine hypertension syndromes of adrenal pathogenesis. II. Syndromes due to hyperaldosteronism and hypercortisolism].
    Vaccaro E; Solitro A
    Minerva Med; 1974 Jun; 65(44):2419-37. PubMed ID: 4846105
    [No Abstract]   [Full Text] [Related]  

  • 5. [Primary aldosteronism].
    Krysiak R; Okopień B; Herman ZS
    Przegl Lek; 2007; 64(1):31-6. PubMed ID: 18183829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minireview: primary aldosteronism--changing concepts in diagnosis and treatment.
    Young WF
    Endocrinology; 2003 Jun; 144(6):2208-13. PubMed ID: 12746276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal cysts and hypokalemia in primary aldosteronism: results of long-term follow-up after treatment.
    Novello M; Catena C; Nadalini E; Colussi GL; Baroselli S; Chiuch A; Lapenna R; Bazzocchi M; Sechi LA
    J Hypertens; 2007 Jul; 25(7):1443-50. PubMed ID: 17563567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal and salivary electrolytes in the diagnosis of primary aldosteronism.
    Wilson DR; Laidlaw JC; Ruse JL
    Can Med Assoc J; 1971 Dec; 105(12):1300-5. PubMed ID: 5150332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocorticoid-remediable aldosteronism.
    Halperin F; Dluhy RG
    Endocrinol Metab Clin North Am; 2011 Jun; 40(2):333-41, viii. PubMed ID: 21565670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mineralocorticoid hypertension and hypokalemia.
    Khosla N; Hogan D
    Semin Nephrol; 2006 Nov; 26(6):434-40. PubMed ID: 17275580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandins and hypokalemia.
    Brouhard BH
    J Pediatr; 1985 Nov; 107(5):738-40. PubMed ID: 2997425
    [No Abstract]   [Full Text] [Related]  

  • 12. Secondary aldosteronism: with observations on the definition of hypokalemia.
    Kaplan NM
    Am J Clin Pathol; 1970 Sep; 54(3):316-23. PubMed ID: 4319208
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hypokalemia].
    Muller AF; Veyrat R; Grandchamp A
    Klin Wochenschr; 1968 Dec; 46(23):1241-8. PubMed ID: 5716442
    [No Abstract]   [Full Text] [Related]  

  • 14. Primary Hyperaldosteronism in a Male Patient: A Case Report.
    Duvvuri VA; Pulgam S; Kota SS
    J Assoc Physicians India; 2024 Oct; 72(10):104-106. PubMed ID: 39390874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Idiopathic primary hyperaldosteronism: significance of functional diagnosis].
    Bianda T; Schmid C
    Schweiz Med Wochenschr; 1998 Aug; 128(35):1277-83. PubMed ID: 9782547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New genetic insights in familial hyperaldosteronism.
    Jackson RV; Lafferty A; Torpy DJ; Stratakis C
    Ann N Y Acad Sci; 2002 Sep; 970():77-88. PubMed ID: 12381543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial hyperaldosteronism.
    Torpy DJ; Stratakis CA; Chrousos GP
    Braz J Med Biol Res; 2000 Oct; 33(10):1149-55. PubMed ID: 11004715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypokalemic rhabdomyolysis: a rare manifestation of primary aldosteronism.
    Zavatto A; Concistrè A; Marinelli C; Zingaretti V; Umbro I; Fiacco F; Tinti F; Petramala L; Mitterhofer AP; Letizia C
    Eur Rev Med Pharmacol Sci; 2015 Oct; 19(20):3910-6. PubMed ID: 26531278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Primary hyperaldosteronism].
    Chambaz IC; Pechère-Bertschi A
    Rev Med Suisse; 2011 Sep; 7(308):1736-8, 1740-2. PubMed ID: 21954813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two uncommon causes of mineralocorticoid excess. Syndrome of apparent mineralocorticoid excess and glucocorticoid-remediable aldosteronism.
    Ulick S
    Endocrinol Metab Clin North Am; 1991 Jun; 20(2):269-76. PubMed ID: 1879399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.